HK1112483A1 - 體外製備腫瘤細胞以激活自然殺傷細胞的方法 - Google Patents

體外製備腫瘤細胞以激活自然殺傷細胞的方法

Info

Publication number
HK1112483A1
HK1112483A1 HK08106312.0A HK08106312A HK1112483A1 HK 1112483 A1 HK1112483 A1 HK 1112483A1 HK 08106312 A HK08106312 A HK 08106312A HK 1112483 A1 HK1112483 A1 HK 1112483A1
Authority
HK
Hong Kong
Prior art keywords
vitro
natural killer
tumour cell
killer cells
cell preparations
Prior art date
Application number
HK08106312.0A
Other languages
English (en)
Inventor
W Lowdell Mark
Original Assignee
Ucl Business Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0505508A external-priority patent/GB0505508D0/en
Priority claimed from GB0514288A external-priority patent/GB0514288D0/en
Application filed by Ucl Business Plc filed Critical Ucl Business Plc
Publication of HK1112483A1 publication Critical patent/HK1112483A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4613—Natural-killer cells [NK or NK-T]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0646—Natural killers cells [NK], NKT cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/26—Universal/off- the- shelf cellular immunotherapy; Allogenic cells or means to avoid rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/48—Blood cells, e.g. leukemia or lymphoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/49—Breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
HK08106312.0A 2005-03-17 2008-06-06 體外製備腫瘤細胞以激活自然殺傷細胞的方法 HK1112483A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0505508A GB0505508D0 (en) 2005-03-17 2005-03-17 Method
GB0514288A GB0514288D0 (en) 2005-07-12 2005-07-12 Method
PCT/GB2006/000960 WO2006097743A2 (en) 2005-03-17 2006-03-16 Method for actvating natural killer cells by tumor cell preparation in vitro

Publications (1)

Publication Number Publication Date
HK1112483A1 true HK1112483A1 (zh) 2008-09-05

Family

ID=36992099

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08106312.0A HK1112483A1 (zh) 2005-03-17 2008-06-06 體外製備腫瘤細胞以激活自然殺傷細胞的方法

Country Status (10)

Country Link
US (3) US8257970B2 (zh)
EP (2) EP2399594B1 (zh)
JP (3) JP5663135B2 (zh)
AU (1) AU2006224313B2 (zh)
CA (1) CA2601197C (zh)
DK (1) DK1863905T3 (zh)
ES (1) ES2566335T3 (zh)
HK (1) HK1112483A1 (zh)
PL (1) PL1863905T3 (zh)
WO (1) WO2006097743A2 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2426197A1 (en) 2006-04-14 2012-03-07 Advanced Cell Technology, Inc. Hemangio-colony forming cells
US20110117578A1 (en) * 2008-05-29 2011-05-19 Bruce Acres Biomarker for selecting patients and related methods
WO2011004201A1 (en) * 2009-07-10 2011-01-13 Mark Lowdell Preserved compositions of activated nk cells and methods of using the same
WO2013132256A1 (en) 2012-03-07 2013-09-12 Ucl Business Plc Compositions and methods for treating viral-mediated infection and disease in immunocompromised individuals
WO2013168978A1 (ko) * 2012-05-07 2013-11-14 고려대학교 산학협력단 말초혈액단핵구 유래 자연 살해세포의 유도 및 증식 방법
CN104321425B (zh) * 2012-05-07 2018-08-10 株式会社Nkmax 用于诱导和扩增源自外周血单个核细胞的自然杀伤细胞的方法
EP3973967A1 (en) 2012-12-21 2022-03-30 Astellas Institute for Regenerative Medicine Methods for production of platelets from pluripotent stem cells and compositions thereof
BR112017004270B1 (pt) * 2014-09-04 2023-03-07 Stemcell Technologies Inc Método de ativação de células t ou células nk
US10758567B2 (en) 2015-09-16 2020-09-01 Immune Ventures LLC In vivo priming of natural killer cells
DK3349769T3 (da) * 2015-12-07 2021-03-08 Immune Ventures LLC In vivo priming af naturlige killerceller
BR112019019241A2 (pt) * 2017-03-15 2020-04-14 Immune Ventures LLC preparação de célula de tumor de iniciação
CA3089853A1 (en) 2018-02-01 2019-08-08 Nkmax Co., Ltd. Method of producing natural killer cells and composition for treating cancer
CN113015744A (zh) 2018-08-30 2021-06-22 Hcw生物科技公司 单链嵌合多肽和多链嵌合多肽以及其用途
JP6838750B2 (ja) * 2019-01-21 2021-03-03 株式会社ガイアバイオメディシン Ｎｋ細胞を含む細胞集団の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69834257T2 (de) * 1997-04-30 2007-01-04 Klingemann, Hans Natürliche killerzelllinien und verfahren zu ihrer verwendung
US6849452B1 (en) * 1998-03-03 2005-02-01 Institut Gustave Roussy Methods for activating natural killer (NK) cells and means for carrying out said methods
CA2516455C (en) 2003-02-20 2012-05-01 Seattle Genetics, Inc. Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
US7435596B2 (en) * 2004-11-04 2008-10-14 St. Jude Children's Research Hospital, Inc. Modified cell line and method for expansion of NK cell

Also Published As

Publication number Publication date
PL1863905T3 (pl) 2016-07-29
DK1863905T3 (en) 2016-04-04
US20080166326A1 (en) 2008-07-10
JP5906168B2 (ja) 2016-04-20
EP1863905B1 (en) 2016-01-20
ES2566335T3 (es) 2016-04-12
JP5663135B2 (ja) 2015-02-04
AU2006224313B2 (en) 2011-08-11
JP2015012876A (ja) 2015-01-22
US8257970B2 (en) 2012-09-04
US20140079678A1 (en) 2014-03-20
WO2006097743A2 (en) 2006-09-21
EP2399594A1 (en) 2011-12-28
JP2008536487A (ja) 2008-09-11
WO2006097743A3 (en) 2006-12-14
AU2006224313A1 (en) 2006-09-21
US9655925B2 (en) 2017-05-23
US20120328587A1 (en) 2012-12-27
EP1863905A2 (en) 2007-12-12
JP2013009686A (ja) 2013-01-17
EP2399594B1 (en) 2019-08-14
CA2601197C (en) 2017-06-06
CA2601197A1 (en) 2006-09-21
US8637308B2 (en) 2014-01-28

Similar Documents

Publication Publication Date Title
HK1112483A1 (zh) 體外製備腫瘤細胞以激活自然殺傷細胞的方法
EP1904619A4 (en) METHOD AND DEVICE FOR CELL CULTURE ARRAY
PT2573166T (pt) Métodos para preparar células-t para terapia celular
EP1934361A4 (en) METHODS OF REJUVENING IN VITRO AND IN VIVO CELLS
HK1248523A1 (zh) 用電穿孔向細胞負載抗原
PT2266544T (pt) Método para introdução de substâncias terapêuticas em células
IL194438A (en) Diarrhylthiohydantoin Compounds, Pharmaceuticals Containing Them, Syntheses Methods and In Vitro Methods for Contacting them with Mammalian Cells
IL184262A (en) A method for culturing cells in culture
IL221384A0 (en) Improving il-15 and il-15r-alpha for expression in mammalian cells
EP1855325A4 (en) SOLAR CELL AND METHOD FOR THE PRODUCTION THEREOF
ZA200900905B (en) Modified-galactosyl ceramides for staining and stimulating Natural Killer T cells
GB2411178A8 (en) Apparatus for culturing cells
GB0525579D0 (en) Cell culture vessel
EP1882030A4 (en) DEVICE FOR PROVIDING MEDIA TO CELL CULTURE MODULES
EP2064324A4 (en) SUBSTRATES FOR CELL CULTURE AND MANUFACTURING METHOD THEREFOR
GB0509748D0 (en) Materials and methods relating to cell based therapies
HK1143404A1 (en) Cell for use in the production of exogenous protein, and production process using the cell
EP2145953A4 (en) ACELLULAR SYSTEM FOR THE SYNTHESIS OF PROTEINS FROM CULTURED MAMMAL CELLS
IL206434A0 (en) Bioreactor for cell growth and associated methods
EP1871402A4 (en) EXTRACT OF CULTURE OF FRUIT CELLS FOR THE TREATMENT OF INFLAMMATION
EP1871914A4 (en) METHOD AND COMPOSITIONS FOR INTRODUCING BIOPOLYMERS IN CELLS
EP1953540A4 (en) ELECTROCHEMICAL CELL AND METHOD FOR PRODUCING THE ELECTROCHEMICAL CELL
EP1807508A4 (en) METHODS FOR PREPARING CELLS AND VIRUSES
GB0606671D0 (en) Cell Culture
IL215602A0 (en) Method for the cultivation of cell population in a serum free medium

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200316